日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The critical need for robust decision support in the era of precision cancer therapeutics

在精准癌症治疗时代,迫切需要强有力的决策支持

Markman, Maurie

Effectiveness of Postdischarge Telephone Calls in Reducing Hospital Utilization: Quasi-Randomized Controlled Trial

出院后电话随访在降低住院率方面的有效性:准随机对照试验

Du, Sandie; Anada, Abigail; Montenegro, Maria; Maitland, Maurie; Chuan, Sean; Jose, Sonia; Sihota, Harveer; Cooper, Delia; Rivera, Joanna; Burditt, Dianne; Naruki-van Velzen, Minetaro; MacPherson, Megan

Genome-wide association study of fat content and fatty acid composition of shea tree (Vitellaria paradoxa C.F. Gaertn subsp. paradoxa)

乳木果树(Vitellaria paradoxa CF Gaertn subsp. paradoxa)脂肪含量和脂肪酸组成的全基因组关联研究

Attikora, Affi Jean Paul; Kouassi, Kouakou Alfred; Yao, Saraka Didier Martial; Dago, Dougba Noel; Silué, Souleymane; De Clerck, Caroline; Diarrassouba, Nafan; Alabi, Taofic; Achigan-Dako, Enoch G; Fauconnier, Maurie-Laure; Danthine, Sabine; Lassois, Ludivine

HTRA1 disaggregates α-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species

HTRA1 分解 α-突触核蛋白淀粉样蛋白原纤维,并将其转化为无毒且无能力的物种

Sheng Chen, Anuradhika Puri, Braxton Bell, Joseph Fritsche, Hector H Palacios, Maurie Balch, Macy L Sprunger, Matthew K Howard, Jeremy J Ryan, Jessica N Haines, Gary J Patti, Albert A Davis, Meredith E Jackrel

HtrA1 prevents and reverses α-synuclein aggregation, rendering it non-toxic and seeding incompetent.

HtrA1 可阻止和逆转α-突触核蛋白聚集,使其无毒且不具备成核能力

Chen Sheng, Puri Anuradhika, Bell Braxton, Fritsche Joseph, Palacios Hector, Balch Maurie, Sprunger Macy, Howard Matthew, Patterson Jessica, Patti Gary, Davis Albert, Jackrel Meredith

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer

接受腹腔化疗的III期卵巢癌患者中,有多少比例可能治愈?对NRG/GOG随机临床试验中接受腹腔和静脉化疗治疗III期卵巢癌的长期(≥10年)生存者进行分析

Pitiyarachchi, Omali; Friedlander, Michael; Java, James J; Chan, John K; Armstrong, Deborah K; Markman, Maurie; Herzog, Thomas J; Monk, Bradley J; Backes, Floor; Secord, Angeles Alvarez; Bonebrake, Albert; Rose, Peter G; Tewari, Krishnansu S; Lentz, Samuel S; Geller, Melissa A; Copeland, Larry J; Mannel, Robert S

Selective Inhibition of the Hsp90α Isoform

选择性抑制 Hsp90α 亚型

Mishra, Sanket J; Khandelwal, Anuj; Banerjee, Monimoy; Balch, Maurie; Peng, Shuxia; Davis, Rachel E; Merfeld, Taylor; Munthali, Vitumbiko; Deng, Junpeng; Matts, Robert L; Blagg, Brian S J

A brave new world: Lessons from the COVID-19 pandemic for transitioning to sustainable supply and production

一个崭新的世界:从新冠疫情中汲取经验教训,向可持续供应链和生产转型

Sarkis, Joseph; Cohen, Maurie J; Dewick, Paul; Schröder, Patrick

BIOM-15. SUBVENTRICULAR ZONE INVOLVEMENT IS ASSOCIATED WITH WORSE OUTCOME IN GLIOMA WHO GRADE II INDEPENDENT OF MOLECULAR MARKERS

BIOM-15. 脑室下区受累与II级胶质瘤患者预后不良相关,且与分子标志物无关。

Randall, Leslie M; Monk, Bradley J; Moon, James; Parker, Ricardo; Al-Ghazi, Muthana; Wilczynski, Sharon; Fruehauf, John P; Markman, Maurie; Burger, Robert A; Karschnia, Philipp; Weller, Jonathan; Blobner, Jens; Stoecklein, Veit M; Dorostkar, Mario M; Rejeski, Kai D; Forbrig, Robert; Niyazi, Maximilian; von Baumgarten, Louisa; Dietrich, Jorg; Tonn, Joerg-Christian; Thon, Niklas

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery

腹腔内注射亚微米颗粒紫杉醇(SPP)联合静脉注射卡铂和紫杉醇治疗上皮性卵巢癌患者的II期研究

Mullany, Sally; Miller, David Scott; Robison, Katina; Levinson, Kimberly; Lee, Yi-Chun; Yamada, S Diane; Walker, Joan; Markman, Maurie; Marin, Alyson; Mast, Peter; diZerega, Gere